Dosimetry model for radioactivity localized to intestinal mucosa.
BACKGROUND
This paper provides a new model for calculating radiation-absorbed doses to the full thickness of the small and large intestinal walls, and to the mucosal layers. The model was used to estimate the intestinal radiation doses from yttrium-90-labeled-DOTA-biotin binding to NR-LU-10-streptavidin in patients.


METHODS
We selected model parameters from published data and observations, and used the model to calculate energy-absorbed fractions using the EGS4 radiation transport code. We determined the cumulated (90)Y activity in the small and large intestines of patients from gamma camera images, and calculated absorbed doses to the mucosal layer and to the whole intestinal wall.


RESULTS
The mean absorbed dose to the wall of the small intestine was 16.2 mGy/MBq (60 cGy/mCi) administered from (90)Y localized in the mucosa, and 70 mGy/MBq (260 cGy/mCi) to the mucosal layer within the wall. Doses to the large intestinal wall and to the mucosa of the large intestine were lower than those for the small intestine by a factor of about 2.5. These doses are greater by factors of about 5 to 6 than those that would have been calculated using the standard MIRD models that assume the intestinal activity is in the bowel contents.


CONCLUSIONS
The specific uptake of radiopharmaceuticals in mucosal tissues may lead to dose-related intestinal toxicities. Tissue dosimetry at the sub-organ level is useful for a better understanding of intestinal tract radiotoxicity and associated dose-response relationships.
Pacific Northwest National Laboratory, 902 Battelle Boulevard P7-27, Richland, WA 99352, USA. dr.fisher@pnl.gov
Darrell
D
Fisher
Didier
D
Rajon
Hazel
H
Breitz
Michael
M
Goris
Wesley
W
Bolch
Susan
S
Knox
D006801:Humans; D007413:Intestinal Mucosa / Q000033:anatomy & histology / Q000000981:diagnostic imaging / Q000528:radiation effects*; D008954:Models, Biological; D009010:Monte Carlo Method; D011829:Radiation Dosage; D011859:Radiography